Molecular epidemiology utilizes the same paradigm as traditional epidemiology, but uses biological markers to identify exposure, disease or susceptibility. This book presents the epidemiologic methods pertinant to biological markers. It is designed to enumerate the considerations necessary for valid field research and provides a resource on the salient features of biological indicators.;This book should be of interest to graduate students and researchers in epidemiology and molecular biology, cancer researchers and medical residents.
Format:
CONTRIBUTORS: Paul A. Schulte, Frederica P. Perera
EAN: 9780126323467
COUNTRY: United States
PAGES:
WEIGHT: 800 g
HEIGHT: 229 cm
PUBLISHED BY: Elsevier Science Publishing Co Inc
DATE PUBLISHED: 1998-03-12
CITY:
GENRE: SCIENCE / Life Sciences / Molecular Biology
WIDTH: 152 cm
SPINE:
Book Themes:
Epidemiology and Medical statistics, Molecular biology
"The book is an excellent review of the crucial issues related to the incorporation of new markers of exposure, disease, or susceptibility into epidemiologic investigations... This book is an excellent resource for all researchers involved in the quest to understand the determinants of disease and apply this knowledge to the maintenance of the health of the public."
--SCIENCE
Dr. Schulte is an epidemiologist with interests in education, quantitative risk assessment, health communication, use of biological markers in epidemiologic research, intervention research, and genetics. In recent years, he has conducted extensive research on occupational cancer. He has focused on issues of dissemination of occupational safety and health information. Dr. Schulte is the editor of the textbook entitled, “Molecular Epidemiology: Principles and Practices. He has served as guest editor of the Journal of Occupational Medicine and the American Journal of Industrial Medicine and was on the initial editorial board of Cancer Epidemiology, Biomarkers and Prevention. He also has served as a consultant to various organizations such as the International Agency for Research on Cancer, the National Academy of Sciences, the Medical Research Council of the United Kingdom, WHO, the Pennsylvania Department of Health, the Agency for Toxic Substances and Disease Registry, and the Department of Energy.